TEXAS NEURO REHAB CENTER — History
CCN 452038 | 3-year financial timeline | COVID resilience: 57/100
🛡️ Public data only — no PHI permitted on this instance.
$38M
Latest Revenue (FY2022)
+5.0%
Revenue CAGR (3yr)
11.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $35M | $37M | $38M | +4.4% | +5.0% |
| Operating Expenses | $31M | $34M | $34M | +0.1% | +4.9% |
| Operating Margin | 11.4% | 7.9% | 11.6% | +47.8% | +1.0% |
| Net Income | $4M | $3M | $4M | +54.3% | +6.1% |
| Licensed Beds | 47 | 47 | 47 | +0.0% | +0.0% |
| Total Patient Days | 14,933 | 14,916 | 14,678 | -1.6% | -0.9% |
| Medicare Day % | 26% | 23% | 26% | +15.7% | +0.3% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 57/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +10.3% ($35M → $38M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.0%
This Hospital
+7.6%
State Avg
Latest Margin
11.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $40M | 11.8% |
| FY2024 (proj) | $42M | 11.9% |
| FY2025 (proj) | $44M | 12.0% |